ALLOWAY_HEALTHCARE_LIMITE - Accounts


Company Registration No. SC554962 (Scotland)
ALLOWAY HEALTHCARE LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2018
PAGES FOR FILING WITH REGISTRAR
ALLOWAY HEALTHCARE LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Statement of changes in equity
3
Notes to the financial statements
4 - 8
ALLOWAY HEALTHCARE LIMITED
BALANCE SHEET
AS AT
31 MARCH 2018
31 March 2018
- 1 -
2018
Notes
£
£
Fixed assets
Intangible assets
3
82,557
Tangible assets
4
6,369
Current assets
Stocks
38,747
Debtors
5
163,496
Cash at bank and in hand
96,936
299,179
Creditors: amounts falling due within one year
6
(180,952)
Net current assets
118,227
Total assets less current liabilities
207,153
Provisions for liabilities
(247)
Net assets
206,906
Capital and reserves
Called up share capital
7
87,236
Profit and loss reserves
119,670
Total equity
206,906

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial Period ended 31 March 2018 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the Period in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.

ALLOWAY HEALTHCARE LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 MARCH 2018
31 March 2018
- 2 -
The financial statements were approved by the board of directors and authorised for issue on 24 September 2018 and are signed on its behalf by:
Mr N A Baillie
Director
Company Registration No. SC554962
ALLOWAY HEALTHCARE LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE PERIOD ENDED 31 MARCH 2018
- 3 -
Share capital
Profit and loss reserves
Total
Notes
£
£
£
Period ended 31 March 2018:
Profit and total comprehensive income for the period
-
156,127
156,127
Issue of share capital
7
87,236
-
87,236
Dividends
-
(36,457)
(36,457)
Balance at 31 March 2018
87,236
119,670
206,906
ALLOWAY HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2018
- 4 -
1
Accounting policies
Company information

Alloway Healthcare Limited is a private company limited by shares incorporated in Scotland. The registered office is 21 Alloway, Ayr, KA7 4PY.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

1.3
Intangible fixed assets - goodwill

Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is 10 years.

 

For the purposes of impairment testing, goodwill is allocated to the cash-generating units expected to benefit from the acquisition. Cash-generating units to which goodwill has been allocated are tested for impairment at least annually, or more frequently when there is an indication that the unit may be impaired. If the recoverable amount of the cash-generating unit is less than the carrying amount of the unit, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the unit and then to the other assets of the unit pro-rata on the basis of the carrying amount of each asset in the unit.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Leasehold improvements
10% Straight Line
Fixtures and fittings
10% Straight Line
Computers
15% Straight Line
Motor vehicles
20% Straight Line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

ALLOWAY HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2018
1
Accounting policies
(Continued)
- 5 -
1.5
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.6
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

 

Stocks held for distribution at no or nominal consideration are measured at the lower of replacement cost and cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.7
Cash at bank and in hand

Cash at bank and in hand are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.8
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of direct issue costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.9
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

ALLOWAY HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2018
1
Accounting policies
(Continued)
- 6 -
Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.10
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

1.11
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.12
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to income on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the lease asset are consumed.

Rental income from operating leases is recognised on a straight line basis over the term of the relevant lease. Initial direct costs incurred in negotiating and arranging an operating lease are added to the carrying amount of the leased asset and recognised on a straight line basis over the lease term.

2
Employees

The average monthly number of persons (including directors) employed by the company during the Period was 8.

ALLOWAY HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2018
- 7 -
3
Intangible fixed assets
Goodwill
£
Cost
At 18 January 2017
-
Additions - separately acquired
92,575
At 31 March 2018
92,575
Amortisation and impairment
At 18 January 2017
-
Amortisation charged for the Period
10,018
At 31 March 2018
10,018
Carrying amount
At 31 March 2018
82,557
4
Tangible fixed assets
Leasehold improvements
Fixtures and fittings
Computers
Motor vehicles
Total
£
£
£
£
£
Cost
At 18 January 2017
-
-
-
-
-
Additions
2,050
761
638
4,125
7,574
At 31 March 2018
2,050
761
638
4,125
7,574
Depreciation and impairment
At 18 January 2017
-
-
-
-
-
Depreciation charged in the Period
176
54
82
893
1,205
At 31 March 2018
176
54
82
893
1,205
Carrying amount
At 31 March 2018
1,874
707
556
3,232
6,369
5
Debtors
2018
Amounts falling due within one year:
£
Trade debtors
84,001
Other debtors
79,495
163,496
ALLOWAY HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2018
- 8 -
6
Creditors: amounts falling due within one year
2018
£
Trade creditors
139,034
Corporation tax
39,240
Other taxation and social security
699
Other creditors
1,979
180,952
7
Called up share capital
2018
£
Ordinary share capital
Issued and fully paid
87,236 Ordinary "A" of £1 each
87,236
87,236
8
Operating lease commitments
Lessee

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

2018
£
397,250
9
Related party transactions

The following amounts were outstanding at the reporting end date:

2018
Balance
Amounts owed by related parties
£
Entities with control, joint control or significant influence over the company
70,428

The loans are interest free and repayable on demand.

2018-03-312017-01-18falseCCH SoftwareCCH Accounts Production 2018.200No description of principal activity24 September 2018Mrs S P BaillieMr N A BaillieMr D StriblingMrs F I StriblingSC5549622017-01-182018-03-31SC5549622018-03-31SC554962core:Goodwill2018-03-31SC554962core:LeaseholdImprovements2018-03-31SC554962core:FurnitureFittings2018-03-31SC554962core:ComputerEquipment2018-03-31SC554962core:MotorVehicles2018-03-31SC554962core:CurrentFinancialInstruments2018-03-31SC554962core:ShareCapital2018-03-31SC554962core:RetainedEarningsAccumulatedLosses2018-03-31SC554962core:ShareCapitalOrdinaryShares2018-03-31SC554962bus:Director22017-01-182018-03-31SC554962core:RetainedEarningsAccumulatedLosses2017-01-182018-03-31SC554962core:ShareCapital2017-01-182018-03-31SC554962core:Goodwill2017-01-182018-03-31SC554962core:LeaseholdImprovementscore:LeasedAssetsHeldAsLessee2017-01-182018-03-31SC554962core:FurnitureFittings2017-01-182018-03-31SC554962core:ComputerEquipment2017-01-182018-03-31SC554962core:MotorVehicles2017-01-182018-03-31SC554962core:Goodwillcore:ExternallyAcquiredIntangibleAssets2017-01-182018-03-31SC554962core:LeaseholdImprovements2017-01-182018-03-31SC554962bus:OrdinaryShareClass12017-01-182018-03-31SC554962bus:OrdinaryShareClass12018-03-31SC554962bus:PrivateLimitedCompanyLtd2017-01-182018-03-31SC554962bus:FRS1022017-01-182018-03-31SC554962bus:AuditExemptWithAccountantsReport2017-01-182018-03-31SC554962bus:SmallCompaniesRegimeForAccounts2017-01-182018-03-31SC554962bus:Director12017-01-182018-03-31SC554962bus:Director32017-01-182018-03-31SC554962bus:Director42017-01-182018-03-31SC554962bus:FullAccounts2017-01-182018-03-31xbrli:purexbrli:sharesiso4217:GBP